Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice

Experimental and Molecular Pathology

Volumn 90, Issue 1, 2011, Pages 45-50

  Aléssio, Ana C M ^a   Santos, Célio X C ^b   Debbas, Victor ^b   Oliveira, Laurione C ^a   Haddad, Renato ^a   Annichino Bizzacchi, Joyce M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Apolipoprotein E deficient mice; Atherosclerosis; Folate; Hyperhomocysteinemia; Normal mice (C57BL 6)

Indexed keywords

APOLIPOPROTEIN E; CYANOCOBALAMIN; FOLIC ACID; METHIONINE; PYRIDOXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOPLASMIC RETICULUM STRESS; FOOD COMPOSITION; HYPERHOMOCYSTEINEMIA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET; ENDOPLASMIC RETICULUM; FOLIC ACID; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TIME FACTORS;

MUS;

EID: 78650699075     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.07.008     Document Type: Article

References (31)

1. Alessio A.C., et al. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am. J. Med. Genet. A 2004, 128A:256-260.
2. Bonaa K.H., et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 2006, 354:1578-1588.
3. Boushey C.J., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049-1057.
4. Chen Z., et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10:433-443.
5. Doshi S.N., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1196-1202.
6. Eikelboom J.W., et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 1999, 131:363-375.
7. Hofmann M.A., et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 2001, 107:675-683.
8. Homocysteine Lowering Trialists' Collaboration Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am. J. Clin. Nutr. 2005, 82:806-812.
9. Jakubowski H. The molecular basis of homocysteine thiolactone-mediated vascular disease. Clin. Chem. Lab. Med. 2007, 45:1704-1716.
10. Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J. Physiol. Pharmacol. 2008, 59(Suppl 9):155-167.
11. Lawrence de Koning A.B., et al. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin. Biochem. 2003, 36:431-441.
12. Lee H., et al. Effects of dietary folic acid supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia. Brain Res. 2004, 996:139-147.
13. Lentz S.R. Does homocysteine promote atherosclerosis?. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1385-1386.
14. Lentz S.R., et al. Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys. Circulation 2001, 103:1006-1011.
15. Lonn E., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 2006, 354:1567-1577.
16. Moat S.J., et al. Folate, homocysteine, endothelial function and cardiovascular disease. J. Nutr. Biochem. 2004, 15:64-79.
17. Paigen B., et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68:231-240.
18. Perla-Kaján J., et al. Immunohistochemical detection of N-homocysteinylated proteins in humans and mice. Biomed. Pharmacother. 2008, 62:473-479.
19. Pesonen E., et al. Topography of intimal thickening in the left coronary artery of children compared with the topography of atherosclerosis. Coron. Artery Dis. 1996, 7:459-465.
20. Reeves P.G., et al. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123:1939-1951.
21. Robinson K., et al. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998, 97:437-443.
22. Rubin E.M., et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991, 353:265-267.
23. Saposnik G., et al. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke 2009, 40:1365-1372.
24. Selhub J., et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270:2693-2698.
25. Spence J.D., et al. Vitamin intervention for stroke prevention trial: an efficacy analysis. Stroke 2005, 36:2404-2409.
26. Stary H.C. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987, 64:91-108.
27. The Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002, 288:2015-2022.
28. Toole J.F., et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004, 291:565-575.
29. Troen A.M., et al. The atherogenic effect of excess methionine intake. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15089-15094.
30. Zhou J., et al. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1470-1476.
31. Zhou J., et al. Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice. Atherosclerosis 2003, 168:255-262.